Condition: Major Depressive Disorder · Sponsor: Stanford University
The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).
This description comes directly from the study's public registry record.
Jade T Truong, BS · 408-840-3313 · kellerlab@stanford.edu
Always discuss trial participation with your own doctor first.
| University of Iowa | Iowa City, California, United States | Recruiting |
| Stanford University | Stanford, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07242105